Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer

Por Hiken, Jeffrey F., McDonald, James I., Decker, Keith F., Sanchez, Cesar, Hoog, Jeremy, VanderKraats, Nathan D., Jung, Kyle L., Akinhanmi, Margaret, Rois, Lisa E., Ellis, Matthew J., Edwards, John R.
Publicado no Oncogene (2016)